Search results
Results from the WOW.Com Content Network
By the end of December 2021, 758,891 doses had been administered and 583,609 persons (25% of the targeted population) were fully vaccinated. By the end of March 2022, 818,931 doses had been administered and 640,464 persons were fully vaccinated. By the end of April 2022, 831,318 doses had been administered and 652,422 persons were fully vaccinated.
COVAX began distributing vaccines in February 2021. Though COVAX promised 100 million doses by the end of March, [3] [4] this goal was not reached until 6 July. [5] By mid-August 2021, COVAX delivered 200 million vaccine doses to nearly 140 countries instead of the 600 million doses initially projected.
Phases 2 and 3 clinical trials of COVAX-19 are being conducted in Iran under a co-operation agreement. [8] Phase 2 clinical trials started in May 2021 and Phase 3 trials commenced in August 2021. In the phase 2 trials, 400 Iranian volunteers were injected with either a placebo or the first dose of the vaccine.
Global vaccine sharing scheme COVAX plans to ship enough COVID-19 shots to cover around 3% of the populations of low-income countries in the first half of this year, a World Health Organization ...
COVAX is designed to assist vaccine purchases and distribution for poor and middle-income countries unable to compete in the open market and avoid inequities for vaccine access. [ 6 ] [ 7 ] However, by December 2020, more than 10 billion vaccine doses had been preordered mostly by high-income countries comprising only 14% of the world's ...
Americans are weathering the worst flu season in years, as a number of other respiratory illnesses circulate too, such as COVID-19, RSV and the common cold.
The US delivers Pfizer COVID-19 vaccines to South Africa as part of the COVAX initiative in 2021. South Africa has so far paid R283 million ($20 million) to the organization in December 2020. COVAX has delivered 1.4 million doses of the Pfizer–BioNTech vaccine to the country on 28 June 2021. [67] [68]
For premium support please call: 800-290-4726 more ways to reach us